Immune escape of SARS-CoV-2 Omicron variant from mRNA vaccination-elicited RBD-specific memory B cells.
Sokal, A.; Broketa, M.; Meola, A.; Barba-Spaeth, G.; Fernandez, I.; Fourati, S.; Azzaoui, I.; de La Selle, A.; Vandenberghe, A.; Roeser, A.; Bouvier-Alias, M.; Crickx, E.; Languille, L.; Michel, M.; Godeau, B.; Gallien, S.; Melica, G.; Nguyen, Y.; Zarrouk, V.; Canoui-Poitrine, F.; Noizat-Pirenne, F.; Megret, J.; Pawlotsky, J.-M.; Fillatreau, S.; Simon-Loriere, E.; Weill, J.-C.; Reynaud, C.-A.; Rey, F. A.; Bruhns, P.; Chappert, P.; Mahevas, M.
Show abstract
Memory B cells (MBCs) represent a second layer of immune protection against SARS-CoV-2. Whether MBCs elicited by mRNA vaccines can recognize the Omicron variant is of major concern. We used bio-layer interferometry to assess the affinity against the receptor-binding-domain (RBD) of Omicron spike of 313 naturally expressed monoclonal IgG that were previously tested for affinity and neutralization against VOC prior to Omicron. We report here that Omicron evades recognition from a larger fraction of these antibodies than any of the previous VOCs. Additionally, whereas 30% of these antibodies retained high affinity against Omicron-RBD, our analysis suggest that Omicron specifically evades antibodies displaying potent neutralizing activity against the D614G and Beta variant viruses. Further studies are warranted to understand the consequences of a lower memory B cell potency on the overall protection associated with current vaccines.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses 96%
- ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants 96%
- SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses 96%
Similar papers in this journal
- SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells 95%
- Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 95%
- Functional characterization and lineage analysis of broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics 95%
Similar papers in this journal
- Differential antibody dynamics to SARS-CoV-2 infection and vaccination 97%
- Rapid and lasting generation of B-cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 disease and convalescence 95%
- SARS-CoV-2 genome-wide mapping of CD8 T cell recognition reveals strong immunodominance and substantial CD8 T cell activation in COVID-19 patients 95%
Similar papers in this journal
- Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients 96%
- SARS-CoV-2 mRNA vaccination elicits robust and persistent T follicular helper cell response in humans 96%
- Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination 96%
Similar papers in this journal
- Vaccination reshapes the virus-specific T cell repertoire in unexposed adults 95%
- Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease 94%
- B lymphocytes that enter the germinal center late preferentially differentiate into memory cells that recognize subdominant epitopes 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.